Liquid Chromatography – Webinars and Online Events

This webinar explores the use of high-resolution ion mobility performed on the MOBIE platform for the characterization of different lipid classes starting from phosphatidylcholines and gangliosides.

Attend this webinar to learn about:
- Discover opportunities that exist in clinical research testing for protein biomarkers (particularly in cardiovascular disease)
- Learn the advantages in performing protein quantification at higher flow rates
- Understand the considerations for implementing an LC-MS analysis for protein biomarker quantification in a clinical translational context

How To Increase the Cost Effectiveness for HPLC Separations of Challenging and Matrix-Rich Samples

Watch this webinar to learn about how to rapidly recognize the presence of protein aggregates using UV-VIS, the absorption of a protein aggregate can be obtained using an integrating sphere and much more.

New methods, techniques and efficient data analysis software in liquid chromatography-tandem mass spectrometry (LC-MS/MS) hold the key for accelerating the development of NGBs and increasing their availability.

Watch this webinar to understand the benefits of affinity chromatography in AAV production as well as learn about viral clearance and how affinity chromatography resins can contribute to the overall viral clearance in AAV manufacturing.

As the commercial cannabis industry grows, so do the types of products available. The variety of cannabis products requiring pesticide and mycotoxin testing provides unique challenges for analytical chemists. In this webinar, we will discuss some of the common issues faced when performing pesticide and mycotoxin testing and strategies to overcome these problems.

The global market for antibody therapeutics is rising rapidly and newer, engineered modalities such as bi-specific antibodies and antibody fragments are entering clinical studies in record number

Biopharmaceutical companies are transitioning from the development of standard monoclonal antibody therapies to more intricate antibody structures and new genetic medicines. Not only are these molecules more complex, but scientists are also under tremendous pressure to understand molecular liabilities sooner and close the developability gap in a much shorter time frame.

Legalization of medical and recreational cannabis and hemp has led to an expansion of potency testing needs.